Illumina's Jay Flatley tells the story of his 2011 meeting with Roche in a video from Biocom's Speaker Series posted by the San Diego Union-Tribune.

In 2011, Illumina's stock price fell from the $70-a-share to $60-a-share range to about $24 a share, and that, Flatley says, was the impetus for Roche to come calling.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.